598 related articles for article (PubMed ID: 15845466)
1. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
[TBL] [Abstract][Full Text] [Related]
2. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
3. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
5. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
6. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
Chen W; Shen H; Webb A; KuoLee R; Conlan JW
Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
[TBL] [Abstract][Full Text] [Related]
7. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
8. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
[TBL] [Abstract][Full Text] [Related]
9. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
10. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
11. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
13. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
16. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.
Rockx-Brouwer D; Chong A; Wehrly TD; Child R; Crane DD; Celli J; Bosio CM
PLoS One; 2012; 7(5):e37752. PubMed ID: 22662210
[TBL] [Abstract][Full Text] [Related]
17. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
[TBL] [Abstract][Full Text] [Related]
18. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis.
Jia Q; Lee BY; Clemens DL; Bowen RA; Horwitz MA
Vaccine; 2009 Feb; 27(8):1216-29. PubMed ID: 19126421
[TBL] [Abstract][Full Text] [Related]
19. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
Shen H; Chen W; Conlan JW
Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
[TBL] [Abstract][Full Text] [Related]
20. Expansion and retention of pulmonary CD4
Roberts LM; Wehrly TD; Crane DD; Bosio CM
Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
